Source link : https://www.newshealth.biz/health-news/disposable-cgm-approved-mounjaro-tied-to-reduced-mortality-benefits-of-lignins/
Medtronic announced FDA approval of its first disposable, all-in-one continuous glucose monitor (CGM) Simplera, which is half the size of the maker’s previous devices. Over a median follow-up of 10.5 months, the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro) for adults with type 2 diabetes was associated with a 42% reduced risk of death, a 20% […]
Author : News Health
Publish date : 2024-08-13 17:58:36
Copyright for syndicated content belongs to the linked Source.
in Health